Abraham Lieberman

6.2k total citations
157 papers, 4.3k citations indexed

About

Abraham Lieberman is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Abraham Lieberman has authored 157 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Neurology, 29 papers in Psychiatry and Mental health and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Abraham Lieberman's work include Parkinson's Disease Mechanisms and Treatments (79 papers), Neurological disorders and treatments (48 papers) and Cerebral Palsy and Movement Disorders (15 papers). Abraham Lieberman is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (79 papers), Neurological disorders and treatments (48 papers) and Cerebral Palsy and Movement Disorders (15 papers). Abraham Lieberman collaborates with scholars based in United States, United Kingdom and Canada. Abraham Lieberman's co-authors include Menek Goldstein, Mark J. Kupersmith, Leonard Diller, Alan Ranhosky, David C. Korts, Julius Korein, Albert Goodgold, Andreas Neophytides, Oleg V. Kopyov and Christopher Duma and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Abraham Lieberman

154 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abraham Lieberman United States 34 2.3k 973 881 689 389 157 4.3k
Olivier Blin France 38 1.8k 0.8× 1.0k 1.0× 1.2k 1.4× 1.2k 1.7× 504 1.3× 170 4.9k
Robert L. Rodnitzky United States 34 2.5k 1.1× 893 0.9× 629 0.7× 413 0.6× 303 0.8× 74 4.0k
E. Martignoni Italy 41 2.8k 1.2× 1.3k 1.3× 733 0.8× 1.3k 1.9× 526 1.4× 172 6.1k
G M Stern United Kingdom 41 3.8k 1.7× 1.6k 1.6× 583 0.7× 650 0.9× 641 1.6× 111 5.7k
Marcelo Merello Argentina 37 2.8k 1.2× 815 0.8× 623 0.7× 647 0.9× 201 0.5× 142 3.7k
Lucien Côté United States 35 3.1k 1.3× 1.4k 1.5× 682 0.8× 535 0.8× 752 1.9× 59 4.8k
A. J. Lees United Kingdom 24 2.5k 1.1× 962 1.0× 560 0.6× 506 0.7× 216 0.6× 46 3.4k
L. Côté United States 32 2.4k 1.0× 816 0.8× 392 0.4× 489 0.7× 446 1.1× 51 3.5k
Rivka Inzelberg Israel 35 2.3k 1.0× 840 0.9× 994 1.1× 537 0.8× 514 1.3× 110 4.4k
Miguel Coelho Portugal 33 4.0k 1.8× 1.4k 1.4× 706 0.8× 688 1.0× 586 1.5× 103 5.3k

Countries citing papers authored by Abraham Lieberman

Since Specialization
Citations

This map shows the geographic impact of Abraham Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Lieberman more than expected).

Fields of papers citing papers by Abraham Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Lieberman. The network helps show where Abraham Lieberman may publish in the future.

Co-authorship network of co-authors of Abraham Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Lieberman. A scholar is included among the top collaborators of Abraham Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Lieberman. Abraham Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lockhart, Thurmon E., et al.. (2023). Effects of protective step training on proactive and reactive motor adaptations in Parkinson’s disease patients. Frontiers in Neurology. 14. 1211441–1211441. 4 indexed citations
2.
Lieberman, Abraham, et al.. (2019). Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis. Frontiers in Neurology. 10. 424–424. 26 indexed citations
3.
Lockhart, Thurmon E., et al.. (2019). Motor Learning Deficits in Parkinson's Disease (PD) and Their Effect on Training Response in Gait and Balance: A Narrative Review. Frontiers in Neurology. 10. 62–62. 98 indexed citations
4.
5.
Shill, Holly A., et al.. (2016). Polestriding Intervention Improves Gait and Axial Symptoms in Mild to Moderate Parkinson Disease. Archives of Physical Medicine and Rehabilitation. 98(4). 613–621. 5 indexed citations
6.
Lieberman, Abraham, et al.. (2013). Finger displacement in Parkinson disease: up? down? sideways?. International Journal of Neuroscience. 124(5). 339–343. 2 indexed citations
7.
Papapetropoulos, Spyridon, Abraham Lieberman, Jeffrey S. Gonzalez, & Deborah C. Mash. (2005). Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?. Acta Neurologica Scandinavica. 111(6). 353–359. 25 indexed citations
8.
Jacques, Deane B., et al.. (1999). Outcomes and Complications of Fetal Tissue Transplantation in Parkinson’s Disease. Stereotactic and Functional Neurosurgery. 72(2-4). 219–224. 19 indexed citations
9.
Kopyov, Oleg V., et al.. (1998). Safety of Intrastriatal Neurotransplantation for Huntington's Disease Patients. Experimental Neurology. 149(1). 97–108. 150 indexed citations
10.
Lieberman, Abraham. (1997). Hitler's Parkinson's disease began in 1933. Movement Disorders. 12(2). 239–240. 5 indexed citations
11.
Kopyov, Oleg V., et al.. (1997). Outcome Following Intrastriatal Fetal Mesencephalic Grafts for Parkinson's Patients Is Directly Related to the Volume of Grafted Tissue. Experimental Neurology. 146(2). 536–545. 46 indexed citations
12.
Lieberman, Abraham. (1992). An Integrated Approach to Patient Management in Parkinson’s Disease. Neurologic Clinics. 10(2). 553–565. 11 indexed citations
13.
Lieberman, Abraham. (1990). Adrenal Transplants Revisited. Mayo Clinic Proceedings. 65(3). 427–430. 2 indexed citations
14.
Alpert, Murray, Anna D. Rosen, Joan Welkowitz, & Abraham Lieberman. (1990). Interpersonal communication in the context of dementia. Journal of Communication Disorders. 23(4-5). 337–346. 5 indexed citations
15.
Borod, Joan C., Murray Alpert, Alizah Z. Brozgold, et al.. (1989). A preliminary comparison of flat affect schizophrenics and brain-damaged patients on meausres of affective processing. Journal of Communication Disorders. 22(2). 93–104. 56 indexed citations
16.
Lieberman, Abraham. (1988). Treatment of Parkinson's Disease. Mayo Clinic Proceedings. 63(10). 1046–1049. 3 indexed citations
17.
Lieberman, Abraham, Elizabeth Helmer, Max Koslow, et al.. (1988). Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients. Annals of Neurology. 24(5). 685–688. 8 indexed citations
18.
Lieberman, Abraham, et al.. (1982). Long Term Survival among Patients with Malignant Brain Tumors. Neurosurgery. 10(4). 450–453. 59 indexed citations
19.
Lieberman, Abraham, Andreas Neophytides, Mark J. Kupersmith, et al.. (1979). Treatment of Parkinsonʼs disease with dopamine agonists: A review. The American Journal of the Medical Sciences. 278(1). 65–76. 12 indexed citations
20.
Goldstein, Menek, et al.. (1978). Dopaminephilic properties of ergot alkaloids.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(8). 2202–6. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Blin Breakdown of academic impact, for papers by Robert L. Rodnitzky Breakdown of academic impact, for papers by E. Martignoni Breakdown of academic impact, for papers by G M Stern Breakdown of academic impact, for papers by Marcelo Merello Breakdown of academic impact, for papers by Lucien Côté Breakdown of academic impact, for papers by A. J. Lees Breakdown of academic impact, for papers by L. Côté Breakdown of academic impact, for papers by Rivka Inzelberg Breakdown of academic impact, for papers by Miguel Coelho
Rankless by CCL
2026